Cellarity
Kristen Marino is a Senior Principal Scientist at Cellarity, leading molecular modeling efforts for Myelofibrosis and NASH programs since November 2022. Previously, Kristen served as Principal Scientist in Computational Chemistry where her work on the sickle-cell disease program resulted in two published patents and significant advancements in compound prioritization and analysis. With a robust background in computational chemistry and protein modeling across companies such as LifeMine Therapeutics and Silicon Therapeutics, Kristen has extensive experience in molecular dynamics simulations, druggability analysis, and the integration of biophysics data. Kristen's academic credentials include a PhD in Chemical Engineering from Princeton University and a Bachelor's Degree from Lehigh University.
This person is not in any teams
This person is not in any offices
Cellarity
1 followers
Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The company’s broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.